142 related articles for article (PubMed ID: 37536956)
1. Teaching NeuroImage: Branching Dura Mater in Primary CNS ALK-Positive Anaplastic Large Cell Lymphoma.
Rattanawong W; Tekarnjnavanit A; Marukatat C; Hemachudha P; Pongpitakmetha T; Anukoolwittaya P
Neurology; 2023 Oct; 101(17):766-768. PubMed ID: 37536956
[No Abstract] [Full Text] [Related]
2. Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.
Kim MK; Cho CH; Sung WJ; Ryoo HM; Lee HJ; Youn SW; Park KK
Int J Clin Exp Pathol; 2013; 6(8):1643-51. PubMed ID: 23923083
[TBL] [Abstract][Full Text] [Related]
3. ALK-1-negative anaplastic large-cell lymphoma presenting as a dura-based mass in an infant.
Ahuja N; Sharma R; Gupta K; Tiewsoh K; Salunke P; Gendle C; Jain R; Trehan A
Clin Neuropathol; 2021; 40(6):347-353. PubMed ID: 34032206
[TBL] [Abstract][Full Text] [Related]
4. [A case of primary central nervous system anaplastic lymphoma kinase positive anaplastic large cell lymphoma manifested as a unilateral pachymeningits].
Fujisawa E; Shibayama H; Mitobe F; Katada F; Sato S; Fukutake T
Rinsho Shinkeigaku; 2017 Nov; 57(11):705-710. PubMed ID: 29070753
[TBL] [Abstract][Full Text] [Related]
5. Primary Central Nervous System Anaplastic Large Cell Lymphoma, ALK Positive.
Ahrendsen JT; Ta R; Li J; Weinberg OK; Ferry JA; Hasserjian RP; Meredith DM; Varma H; Sadigh S; Michaels PD
Am J Clin Pathol; 2022 Aug; 158(2):300-310. PubMed ID: 35460414
[TBL] [Abstract][Full Text] [Related]
6. ALK-negative anaplastic large cell lymphoma with JAK2 rearrangement mimicking classic Hodgkin lymphoma.
Jaye DL; Feldman AL
Blood; 2023 Apr; 141(17):2160. PubMed ID: 37103947
[No Abstract] [Full Text] [Related]
7. Primary anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma of the breast in a male patient.
Ko ES; Seol H; Shin JH; Ko EY
Br J Radiol; 2012 Apr; 85(1012):e79-82. PubMed ID: 22457412
[TBL] [Abstract][Full Text] [Related]
8.
Savage KJ; Slack GW
Haematologica; 2023 Jun; 108(6):1463-1467. PubMed ID: 36453106
[No Abstract] [Full Text] [Related]
9. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
Wang CX; Wang H; Li J; Ma HH; Yu B; Shi SS; Zhou XJ; Shi QL
Int J Clin Exp Pathol; 2014; 7(3):1182-7. PubMed ID: 24696735
[TBL] [Abstract][Full Text] [Related]
10. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
Oschlies I; Lisfeld J; Lamant L; Nakazawa A; d'Amore ES; Hansson U; Hebeda K; Simonitsch-Klupp I; Maldyk J; Müllauer L; Tinguely M; Stücker M; Ledeley MC; Siebert R; Reiter A; Brugières L; Klapper W; Woessmann W
Haematologica; 2013 Jan; 98(1):50-6. PubMed ID: 22773605
[TBL] [Abstract][Full Text] [Related]
11. ALK-negative CNS anaplastic large cell lymphoma: case report and review of literature.
Lannon M; Lu JQ; Chum M; Wang BH
Br J Neurosurg; 2023 Oct; 37(5):1245-1250. PubMed ID: 33253051
[TBL] [Abstract][Full Text] [Related]
12. β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Anand M; Lai R; Gelebart P
Haematologica; 2011 Feb; 96(2):253-61. PubMed ID: 20971814
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma.
Christensen JG; Zou HY; Arango ME; Li Q; Lee JH; McDonnell SR; Yamazaki S; Alton GR; Mroczkowski B; Los G
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3314-22. PubMed ID: 18089725
[TBL] [Abstract][Full Text] [Related]
14. [Anaplastic lymphoma kinase positive anaplastic large cell lymphoma with cardiac infiltration: a case report].
Yuan FF; Yin QS; Mi RH; Chen L; Xiong YY; Wei XD; Song YP
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):351-352. PubMed ID: 32375454
[No Abstract] [Full Text] [Related]
15. "Double hit" anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements.
Luo DX; Li W; Ye MT; Yang Y; Tang G; You MJ
Am J Hematol; 2020 Dec; 95(12):1625-1627. PubMed ID: 32833271
[No Abstract] [Full Text] [Related]
16. Targeting Anaplastic Lymphoma Kinase in GI Primary Malignancies.
Loh J; Ang YLE; Jain A; Yeong J; Sundar R
JCO Precis Oncol; 2022 Jul; 6():e2200208. PubMed ID: 35939772
[No Abstract] [Full Text] [Related]
17. Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.
Mossé YP; Lim MS; Voss SD; Wilner K; Ruffner K; Laliberte J; Rolland D; Balis FM; Maris JM; Weigel BJ; Ingle AM; Ahern C; Adamson PC; Blaney SM
Lancet Oncol; 2013 May; 14(6):472-80. PubMed ID: 23598171
[TBL] [Abstract][Full Text] [Related]
18. ALK-positive anaplastic large cell lymphoma presenting as intradural spinal mass: first reported case and review of literature.
Novello M; Lauriola L; Della Pepa GM; La Rocca G; Coli A; Visocchi M
Neuropathology; 2013 Aug; 33(4):418-23. PubMed ID: 23082771
[TBL] [Abstract][Full Text] [Related]
19. IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
Shi P; Lai R; Lin Q; Iqbal AS; Young LC; Kwak LW; Ford RJ; Amin HM
Blood; 2009 Jul; 114(2):360-70. PubMed ID: 19423729
[TBL] [Abstract][Full Text] [Related]
20. Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic Lymphoma Kinase‒Positive Anaplastic Large Cell Lymphoma.
Xu W; Kim JW; Jung WJ; Koh Y; Yoon SS
Cancer Res Treat; 2018 Apr; 50(2):599-613. PubMed ID: 28675026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
